Moderna COVID Vaccine Approved: FDA & Restrictions

The ‍FDA has approved Moderna‘s novel mNexspike COVID vaccine, representing a pivotal advancement in the fight against the virus. However, this ‍approval arrives with specific usage restrictions differentiating it from Moderna’s earlier Spikevax shot. This crucial update designates the mNexspike vaccine⁤ for individuals aged 65 and older or those facing elevated health risks. News directory 3 is monitoring the unfolding rollout, reporting on the vaccine’s distribution and impact on public health. As the healthcare landscape continues to evolve, this targeted approach signifies a strategic shift in vaccination protocols. Discover what’s next in the ongoing battle against COVID-19.